GLADIATOR

Read time: 4 mins

Are you suffering from Ulcerative Colitis (UC)? 

The GLADIATOR UC Team is looking for people with moderately active UC to join a clinical research study assessing an investigational drug. 

Reasons to participate:

✔ Opportunity to be a part of a clinical study for moderately active UC

✔ Potentially get access to the oral, once-daily, investigational drug at no cost

✔ Be monitored by gastrointestinal (GI) specialists

✔ You may be eligible to join an extension study and receive the investigational drug

Is the GLADIATOR UC Study Right for You?

The answer may be yes, if you:

✔ Are 18 to 80 years of age

✔ Have been diagnosed with moderately active UC ≥ 3 months prior to screening

✔ Did not respond to, are no longer responding to, or did not tolerate another UC therapy

 *There are other eligibility criteria too. Contact the study sites to learn more.

What else do I need to know? If you are eligible and decide to participate:

You’ll get complete information: The study team will explain the possible benefits and risks of the study.
Care and medication provided: All investigational treatment and study-related care will be provided to you at no cost.
Investigational drug vs placebo – You will have a 2-in-3 chance of receiving the investigational drug and a 1-in-3 chance of receiving the placebo. Placebo looks like the investigational drug, but contains no actual medicine. 

There is no obligation and participation in this study is voluntary.

Participating countries in Europe: 

Belgium, Czech Rep., France, Germany, Israel, Italy, Spain

For more information on the countries and participating sites please visit: 

Belgium

Hospitals:

(31002) – AZ Delta, Roeselare

Investigator: Dr. Filip Baert (filip.baert@azdelta.be, +3251237215)

Study Coordinator: Lien Decaesteker (lien.decaesteker@azdelta.be, +3251237512)

(31009) - AZ Sint-Lucas, Gent 

Investigator: Dr. Harald Peeters (harald.peeters@azstlucas.be, 0032 (0)9 224 64 80)

Study Coordinator: Sophie Claeys (sophie.claeys@azstlucas.be, 0032 (0)9 224 51 70)

 

Czech Republic

Hospitals:

(34005) - Hepato-Gastroenterologie HK s.r.o., Hradec, Kralov, 500 12

(34010) - Fakultni nemocnice Ostrava, Ostrava 

Investigator: Dr. Pavel Svoboda (pavel.svoboda@fno.cz)

(34014) - PreventaMed  s.r.o., Olomouc 

Investigator: Dana Mohrova (mohrova@vilazdravi.cz, 420-6044-99100)

 

France*

Hospitals:

(35004) - CHU Rennes - Hôpital Pontchaillou , Rennes

Investigator: Dr. Guillaume Bouguen (guillaume.bouguen@chu-rennes.fr, 0299289972)

Study Coordinator: Cèline Gautier (celine.gautier@chu-rennes.fr, 0299289889 poste 85809)

(35007) - CHU de Grenoble - Hôpital Nord, Grenoble 

(35008) - CHU Nice - Hôpital de l'Archet 2 - URC Gastro-ènterologie, Nice

Investigator: Dr. Xavier Hebuterne (gastro.urc@chu-nice.fr)

(35010) - Centre Hospitalier Universitaire de Nantes - Hotel-Dieu, Nantes Cedex 1, France, 44093

*It is important to discuss this possibility with your general practitioner/family doctor

 

Germany

Hospitals:

(36001) - Charité - Campus Charité Mitte, Berlin 

Investigator: Dr. C. Jochum (christoph.jochum@charite.de , 0049 30450 514102)

Study Coordinator:  (0049 30450 614096)

(36008) - Universitaetsklinikum Schlegswig-Holstein - Campus Kiel 

 

Israel

Hospitals:

(39001) - Rabin Medical Center-Beilinson Campus, Petach Tikva 

Study Coordinator: Maor Pauker (maorhall@clalit.org.il , 972-3-6613785)

(39003) - Kaplan Medical Center, Rehovot 

Investigator: Dr. Bruce N. Mosenkis (mosenkis@clalit.org.il, 972-8-9441587)

Study Coordinator: Meirav Karny (meiravka1@clalit.org.il, 972-8-9441587)

(39005) - Galilee Medical Center, Nahariya

Investigator: Prof. Assy Nimer (nimera@gmc.gov.il, 972-5-07887915)

Study Coordinator: Nelly Bar Guy (nellyb@gmc.gov.il, 972-4-9107265)

(39006) - Shaare Zedek Medical Center, Jerusalem 

Investigator: Prof. Eran Goldin (erang@szmc.org.il, 972 (0) 772260064)

(39008) - Wolfson Medical Center, Holon 

Study Coordinator: Orit Shevah (oritsh@wmc.gov.il)

 

Italy

(40005) - Ospedale San Bortolo - UOC di Gastroenterologia Vicenza  

Investigator: Dr. Paolo Pallini (paolo.pallini@aulss8.veneto.it)

(40007) - Ospedale di Circolo, Rho 

(40021) - Azienda Ospedaliera Saverio De Bellis

Investigator: Dott, Mauro Mastronardi (mauro.mastronardi@irccsdebellis.it , 080 4994279) 

Sub-Investigator: Dott. Natalino Vena (natalino.ven@irccsdebellis.it , 080 4994379) 

(40022) - Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Complesso Integrato Columbus

(40023) - Ospedale San Raffaele

Investigator: Prof. Silvio Danese (ibd.trails@hsr.it , 022 6432069)

Study Coordinator: Carmen Di Matteo (dimatteo.carmen@hsr.it , 022 6439494)

 

Portugal

Hospitals:

(56006) - Centro Hospitalar Universitario de Sao Joao, E.P.E., Porto

 

Spain

Hospitals:

(47003) - Hospital General Universitario de Alicante, Alicante, 28046 

(47005) - Hospital Universitario La Paz, Madrid 

 

 

Project date: 
February, 2023